CXCL9 and neoplasm: However, even in HGSOC itself, this distinguishes CX3CL1 from other T-cell recruiting chemokines such as CXCL9 and CXCL10, which can combat tumour growth in vivo by enhancing lymphocyte infiltration and represent a strong and robust protective prognostic marker [7,24,25].